IN8BIO, INC. Files 8-K on Financials
Ticker: INAB · Form: 8-K · Filed: Mar 13, 2025 · CIK: 1740279
| Field | Detail |
|---|---|
| Company | In8bio, Inc. (INAB) |
| Form Type | 8-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, sec-filing
TL;DR
IN8BIO filed an 8-K on 3/13/25 detailing financial condition and results of operations.
AI Summary
On March 13, 2025, IN8bio, Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, including the presentation of financial statements and exhibits. No specific material events or transactions were detailed in the provided excerpt.
Why It Matters
This 8-K filing provides an update on IN8bio's financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not appear to contain any new material events or negative developments.
Key Numbers
- 001-39692 — Commission File Number (Identifies the company's filing with the SEC.)
- 82-5462585 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- IN8BIO, INC. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- New York (location) — Principal Executive Offices City
FAQ
What is the primary purpose of this 8-K filing by IN8bio, Inc.?
The primary purpose of this 8-K filing is to report on IN8bio, Inc.'s Results of Operations and Financial Condition, including the presentation of Financial Statements and Exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on March 13, 2025.
What is IN8bio, Inc.'s state of incorporation?
IN8bio, Inc. is incorporated in Delaware.
What is the address of IN8bio, Inc.'s principal executive offices?
The address of IN8bio, Inc.'s principal executive offices is 350 5th Avenue, Suite 5330, New York, New York 10118.
Does the filing mention any specific new business developments or material events?
Based on the provided excerpt, the filing focuses on financial condition and results of operations, and does not detail any specific new business developments or material events.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 13, 2025 regarding IN8BIO, INC. (INAB).